BioVaxys Technology Corp.

BVAXF · OTC
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Operating Activities
Net Income-$910-$1,317-$1,070-$2,744
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$71$0$71$259
Change in WC-$38$971$285$136
Other Non-Cash-$179$337-$179$1,334
Operating Cash Flow-$1,057-$8-$893-$1,015
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$1,056$0$0$0
Investing Cash Flow$1,056$0$0$0
Financing Activities
Debt Repay.$0$0$0-$14
Stock Issued$0$970$814$747
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$67$33$0
Financing Cash Flow$0$904$847$733
Forex Effect$0$8-$9$3
Net Chg. in Cash-$0-$153-$54-$279
Supplemental Information
Beg. Cash$4$157$212$491
End Cash$4$4$157$212
Free Cash Flow-$1,057-$1,065-$893-$1,015
BioVaxys Technology Corp. (BVAXF) Financial Statements & Key Stats | AlphaPilot